Stephen J. Haggarty

Harvard Medical School, Boston, MA, United States 
neuroplasticity, chromatin, neural stem cells
"Stephen Haggarty"
Mean distance: 16.25 (cluster 23)
Cross-listing: Neurotree


Sign in to add mentor
Stuart L. Schreiber grad student 2003 Harvard
 (Mapping biochemical space using multidimensional chemical genetics and graph theory.)


Sign in to add trainee
Joshua A. Bishop post-doc 2011-2013 MGH
Jasmin Lalonde post-doc 2012-2017 Harvard Medical School (Neurotree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Walczyk Mooradally A, Holborn J, Singh K, et al. (2021) Phosphorylation-Dependent control of arc protein by TNIK. Journal of Neurochemistry
Patnaik D, Pao PC, Zhao WN, et al. (2021) Exifone Is a Potent HDAC1 Activator with Neuroprotective Activity in Human Neuronal Models of Neurodegeneration. Acs Chemical Neuroscience
Kovalenko M, Erdin S, Andrew MA, et al. (2020) Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice. Elife. 9
Haggarty SJ, Karmacharya R, Perlis RH. (2020) Advances toward precision medicine for bipolar disorder: mechanisms & molecules. Molecular Psychiatry
Pao PC, Patnaik D, Watson LA, et al. (2020) HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer's disease. Nature Communications. 11: 2484
Zhao WN, Tobe BTD, Udeshi ND, et al. (2020) Discovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion. Translational Psychiatry. 10: 76
Zimmerman AJ, Hafez AK, Amoah SK, et al. (2020) A psychiatric disease-related circular RNA controls synaptic gene expression and cognition. Molecular Psychiatry
Petcherski A, Chandrachud U, Butz ES, et al. (2019) An Autophagy Modifier Screen Identifies Small Molecules Capable of Reducing Autophagosome Accumulation in a Model of CLN3-Mediated Neurodegeneration. Cells. 8
Bernard-Gauthier V, Mossine AV, Knight A, et al. (2019) Structural Basis for Achieving GSK-3 Inhibition with High Potency, Selectivity and Brain Exposure for PET Imaging and Drug Discovery. Journal of Medicinal Chemistry
Moreno-Yruela C, Fass DM, Cheng C, et al. (2019) Kinetic Tuning of HDAC Inhibitors Affords Potent Inducers of Progranulin Expression. Acs Chemical Neuroscience
See more...